Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

Jennifer E. Tseng, Bonnie S. Glisson, Fadlo R. Khuri, Dong M. Shin, Jeffrey N. Myers, Adel K. El-Naggar, Jennifer S. Roach, Lawrence E. Ginsberg, Peter F. Thall, Xuemei Wang, Stephanie Teddy, Kristie N. Lawhorn, Rebecca E. Zentgraf, Ganene D. Steinhaus, James M. Pluda, James L. Abbruzzese, Waun Ki Hong, Roy S. Herbst

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Medicine & Life Sciences